These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4390765)

  • 1. Inhibitory effects of various agents on the activity of tropinesterases.
    Otorii T
    Acta Med Biol (Niigata); 1969 Sep; 17(2):177-91. PubMed ID: 4390765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiparkinson agents. 50].
    Schmutzler F; Eichhorn A
    Pharm Prax; 1970; 12():285-92. PubMed ID: 4396459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of drugs on fall-out nystagmus and Bekhterev nystagmus].
    Epshteĭn EP
    Kosm Biol Med; 1972; 6(6):34-8. PubMed ID: 4148630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibitory effect of parasympatholytics on serum cholinesterase in vitro].
    Patocka J
    Cesk Farm; 1971 Nov; 20(9):347-8. PubMed ID: 4400169
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacologic basis of bronchospasmolytic agents.
    Preisig R
    Respiration; 1969; 26():Suppl:95-102. PubMed ID: 4392519
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in cochlear blood flow in guinea pigs in response to autonomic drugs and vasodilating agents.
    Suga F; Snow JB
    Surg Forum; 1968; 19():479-80. PubMed ID: 5718713
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-activity relationships of drugs affecting the lungs.
    AVIADO DM
    J Pharm Sci; 1962 Mar; 51():191-201. PubMed ID: 13863402
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of cholinesterase inhibition on the visual evoked potentials in the rabbit and their modification with various drugs.
    Rump S; Rabsztyn T; Kopeć J
    Act Nerv Super (Praha); 1974 Aug; 16(3):224-5. PubMed ID: 4418665
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinesterase inhibition by phenothiazine and nonphenothiazine antihistaminics: analysis of its postulated role in synergizing organophosphate toxicity.
    Fernández G; Díaz Gómez MI; Castro JA
    Toxicol Appl Pharmacol; 1975 Feb; 31(2):179-90. PubMed ID: 236606
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacology of ethmosine].
    Kaverina NV; Senova ZP; Mitrofanov VS; Runova MF
    Farmakol Toksikol; 1972; 35(2):182-5. PubMed ID: 4401791
    [No Abstract]   [Full Text] [Related]  

  • 11. The possible adverse effects of over-the-counter medications on the contact lens wearer.
    Chang FW
    J Am Optom Assoc; 1977 Mar; 48(3):319-23. PubMed ID: 68045
    [No Abstract]   [Full Text] [Related]  

  • 12. Further observations on the spasmogenic activity of caerulein on the rat pylorus.
    Bertaccini G; Impicciatore M; De Caro G; Chiavarini M; Burani A
    Pharmacol Res Commun; 1974 Feb; 6(1):23-34. PubMed ID: 4154459
    [No Abstract]   [Full Text] [Related]  

  • 13. [Collateral effects of antiparkinsonian agents used in psychiatry].
    Daniel Falcón H
    Neurol Neurocir Psiquiatr; 1976; 17(1):47-55. PubMed ID: 29247
    [No Abstract]   [Full Text] [Related]  

  • 14. Histamine methyltransferase: inhibition and potentiation by antihistamines.
    Taylor KM; Snyder SH
    Mol Pharmacol; 1972 May; 8(3):300-10. PubMed ID: 4402747
    [No Abstract]   [Full Text] [Related]  

  • 15. [Substances decreasing the aggregation and adhesiveness of thrombocytes (review of the literature)].
    Lakin KM; Fel'dbaum VA; Lebedeva AA
    Farmakol Toksikol; 1971; 34(1):104-13. PubMed ID: 4397898
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta- and para-hydroxy-1-cyanophenethylamines.
    Pinder RM; Burger A; Ariëns EJ
    Arzneimittelforschung; 1970 Feb; 20(2):245-6. PubMed ID: 4392556
    [No Abstract]   [Full Text] [Related]  

  • 17. [A molecular basis for the action of drugs. I. Receptor-theory and structure-effect relations].
    Ariëns EJ
    Arzneimittelforschung; 1966 Nov; 16(11):1376-95. PubMed ID: 4386673
    [No Abstract]   [Full Text] [Related]  

  • 18. [Spasmolytic effect of 5,5-diphenyl-2-(2'-piperidino-ethyl)-1,3-dioxclan-4-one HCl, a new spasmolytic].
    Mörsdorf K; Wengenroth H; Pailer M
    Arzneimittelforschung; 1969 Nov; 19(11):1855-60. PubMed ID: 4391791
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation and pharmacological activities of 10-homolupinanoyl-2-R-phenothiazines.
    Sparatore A; Sparatore F
    Farmaco; 1994 Jan; 49(1):5-17. PubMed ID: 7910463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of cholinergic potentiation of tranquilizer activity.
    Saxena PN
    Indian J Physiol Pharmacol; 1968 Jan; 12(1):53-7. PubMed ID: 4970598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.